ALG Manousakis Law Firm sponsored and participated in the GC Summit: Greece 2026, hosted by Legal 500 on June 18 at the N.J.V. Athens Plaza in Athens.
Our colleagues Panagiotis Polychronopoulos (Senior Associate) and Chara Grigoriadou (Associate) joined Evi Mathiou (Legal, Compliance & Quality Associate Director at Novo Nordisk), Eleana Nikolopoulou (Director, Legal & Compliance at Lavipharm) and Xenia Kyriopoulou (Head of Legal, Elpen Pharmaceutical Co.) for the panel discussion “The Rise of Bio-Manufacturing Hubs in Greece”.
The discussion explored Greece’s growing potential as a destination for life sciences and bio-manufacturing investment, including the role of AI, R&D incentives, patent box incentives and streamlined licensing frameworks for strategic investments.
For ALG Manousakis Law Firm, the GC Summit was an opportunity to exchange views with leading in-house counsel and contribute practical legal insight on structuring life sciences investments, managing regulatory and IP risks, and navigating an evolving investment environment.
In addition to our panel participation, ALG Manousakis Law Firm was represented throughout the Summit by Ioannis Manousakis (Managing Partner), Alexandros Manousakis (Senior Partner), Ioannis Stathakis (Junior Partner), Konstantinos Arvanitopoulos (Junior Partner), Eleni Gerou (Senior Associate), Panagiota Tentzoglidi (Senior Associate), Danai Panopoulou (Associate) and Anastasia Fakitsa (Junior Associate), reflecting our firm’s ongoing commitment to engaging with the legal community and supporting discussions on the issues shaping the future of business and law.
